Pharma Journalist - Page 769 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

FDA Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria

Sanofi to acquire Protein Sciences

BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada)

Abzena and OBI Pharma Sign ThioBridge Licence Agreement

CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Center

InMed Pharmaceuticals Signs R&D Agreement with ATERA

Eurofins Has Signed an Exclusive Agreement to Acquire Amatsigroup

Zydus starts phase II trial of ZYAN1 for treating anemia in patients with CKD

FDA grants SOBI003 Orphan Drug Designation for the treatment of MPS IIIA

Exscientia Enters Strategic Drug Discovery Collaboration with GSK